Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.

[1]  Masaru Tomita,et al.  Metabolomic profiling of anionic metabolites by capillary electrophoresis mass spectrometry. , 2009, Analytical chemistry.

[2]  M. Graeber.  Biomarkers for Parkinson's disease , 2009, Experimental Neurology.

[3]  John T. Wei,et al.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.

[4]  M. Suematsu,et al.  Cystathionine β‐synthase as a carbon monoxide–sensitive regulator of bile excretion , 2009, Hepatology.

[5]  A. Baranova,et al.  A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH) , 2008, Obesity surgery.

[6]  W. Matson,et al.  Metabolomic profiling to develop blood biomarkers for Parkinson's disease. , 2008, Brain : a journal of neurology.

[7]  J. Bruix,et al.  Treatment of hepatocellular carcinoma. , 2006, Critical reviews in oncology/hematology.

[8]  M. Tomita,et al.  Differential Metabolomics Reveals Ophthalmic Acid as an Oxidative Stress Biomarker Indicating Hepatic Glutathione Consumption* , 2006, Journal of Biological Chemistry.

[9]  M. Ziol,et al.  Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis. , 2006, Cancer research.

[10]  K. Koike,et al.  Oxidative stress and hepatitis C viral infection. , 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

[11]  Frederick P Roth,et al.  Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia , 2005, Circulation.

[12]  H. Çelik,et al.  Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection , 2005, BMC infectious diseases.

[13]  Douglas B. Kell,et al.  Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning , 2005, Metabolomics.

[14]  M. Miyazaki,et al.  PIVKA-II-producing advanced gastric cancer , 2004, International Journal of Clinical Oncology.

[15]  M. Tomita,et al.  Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. , 2003, Journal of proteome research.

[16]  P. Silverman,et al.  Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma. , 2003, AJR. American journal of roentgenology.

[17]  C. Harris,et al.  Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma. , 2001, Journal of the National Cancer Institute.

[18]  S. Bonner-Weir,et al.  Activation of the Hexosamine Pathway Leads to Deterioration of Pancreatic β-Cell Function through the Induction of Oxidative Stress* , 2001, The Journal of Biological Chemistry.

[19]  K. Koike,et al.  Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. , 2001, Cancer research.

[20]  Kutay,et al.  The effects of chronic hepatitis C and B virus infections on liver reduced and oxidized glutathione concentrations. , 2000, Hepatology research : the official journal of the Japan Society of Hepatology.

[21]  B. Babior.  Phagocytes and oxidative stress. , 2000, The American journal of medicine.

[22]  P. Boya,et al.  Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C. , 1999, Journal of hepatology.

[23]  Y. Sugiyama,et al.  Species differences in the transport activity for organic anions across the bile canalicular membrane. , 1999, The Journal of pharmacology and experimental therapeutics.

[24]  E. Stadtman,et al.  Methionine residues may protect proteins from critical oxidative damage , 1999, Mechanisms of Ageing and Development.

[25]  L. Lash,et al.  Depletion of glutathione in the kidney and the renal disposition of administered inorganic mercury. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[26]  S. Williams,et al.  The distribution of theta-class glutathione S-transferases in the liver and lung of mouse, rat and human. , 1996, The Biochemical journal.

[27]  J. Yodoi,et al.  Persistent oxidative stress in cancer , 1995, FEBS letters.

[28]  M. Kudo,et al.  Des-γ-carboxy prothrombin (PIVKA-II) and α-fetoprotein producing IIc-type early gastric cancer , 1992 .

[29]  A. Meister,et al.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). , 1979, The Journal of biological chemistry.

[30]  杨军,et al.  Plasma Phospholipid Metabolic Profiling and Biomarkers of Type 2 Diabetes Mellitus Based on High Performance Liquid Chromatography/Electrospray Mass Spectrometry and Multivariate Statistical Analysis , 2005 .

[31]  E. Brunt.  Nonalcoholic steatohepatitis. , 2004, Seminars in liver disease.

[32]  S. Locarnini.  Molecular virology of hepatitis B virus. , 2004, Seminars in liver disease.

[33]  A. Federico,et al.  Oxidative stress in viral and alcoholic hepatitis. , 2003, Free radical biology & medicine.

[34]  角田 圭雄.  Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection , 2002 .

[35]  Susumu Goto,et al.  LIGAND: database of chemical compounds and reactions in biological pathways , 2002, Nucleic Acids Res..

[36]  W. Vogt.  Oxidation of methionyl residues in proteins: tools, targets, and reversal. , 1995, Free radical biology & medicine.

[37]  M. Kudo,et al.  Des-gamma-carboxy prothrombin (PIVKA-II) and alpha-fetoprotein-producing IIc-type early gastric cancer. , 1992, The American journal of gastroenterology.

[38]  M. Colombo,et al.  Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. , 1986, Journal of hepatology.